55513-0164 Kanjinti - CanMED: NDC

Product NDC:

55513-0164

Brand Name:

Kanjinti

Generic Name:

Traztuzumab-anns

trastuzumab-anns

Dosage Form Name:

KIT

Administration Route:

Intravenous

Substances:

Packages:

Code: 55513-0164-01

Description: 1 KIT in 1 CARTON (55513-164-01) * 1 VIAL, MULTI-DOSE in 1 CARTON (55513-132-01) / 20 mL in 1 VIAL, MULTI-DOSE * 20 mL in 1 VIAL (55513-152-01)

Effective Date: Feb. 1, 2023

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

HER2

Orphan Drug Designation:

No

Status:

In Use

CanMED and the Oncology Toolbox

CanMED: NDC